Gene · 3036
Papers4,320
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 4,320
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Perspectives for Improving the Tumor Targeting of Nanomedicine via the EPR Effect in Clinical Tumors. | Int J Mol Sci | 2023 | 37373227 | PubTator, text mining | PubMed |
Yedoma Permafrost Releases Organic Matter with Lesser Affinity for Cu2+ and Ni2+ as Compared to Peat from the Non-Permafrost Area: Risk of Rising Toxicity of Potentially Toxic Elements in the Arctic Ocean. | Toxics | 2023 | 37368583 | PubTator, text mining | PubMed |
| Production of Ethyl-agarobioside, a Novel Skin Moisturizer, by Mimicking the Alcoholysis from the Japanese Sake-Brewing Process. | Mar Drugs | 2023 | 37367665 | PubTator, text mining | PubMed |
| Diagnostic and prognostic role of circRNAs in pancreatic cancer: a meta-analysis. | Front Oncol | 2023 | 37361594 | PubTator, text mining | PubMed |
| Protective effect of Schizonepeta tenuifolia Briq. ethanolic extract against UVB-induced skin aging and photodamage in hairless mice. | Front Pharmacol | 2023 | 37351505 | PubTator, text mining | PubMed |
| Safety and effectiveness of intra-articular injection of a highly cross-linked hyaluronic acid, LBSA0103 (Synovian): Results from a post-marketing surveillance study in South Korea. | PLoS One | 2023 | 37347765 | PubTator, text mining | PubMed |
| Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes. | Cancer Rep (Hoboken) | 2023 | 37344125 | PubTator, text mining | PubMed |
| Bioprocess development for universal influenza vaccines based on inactivated split chimeric and mosaic hemagglutinin viruses. | Front Bioeng Biotechnol | 2023 | 37342504 | PubTator, text mining | PubMed |
| Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma. | Front Immunol | 2023 | 37334363 | PubTator, text mining | PubMed |
| Developmental-stage specific single-cell human embryo dissociation. | STAR Protoc | 2023 | 37330906 | PubTator, text mining | PubMed |
| The First Brazilian Cardiovascular Registry of Atrial Fibrillation: Primary Results of the RECALL Study. | Am Heart J | 2023 | 37330162 | PubTator, text mining | PubMed |
| Single-cell and spatial transcriptome analysis reveals the cellular heterogeneity of liver metastatic colorectal cancer. | Sci Adv | 2023 | 37327339 | PubTator, text mining | PubMed |
| The Potential of Artemisinins as Novel Treatment for Thyroid Eye Disease by Inhibiting Adipogenesis in Orbital Fibroblasts. | Invest Ophthalmol Vis Sci | 2023 | 37326592 | PubTator, text mining | PubMed |
| Recent insights into the SWI/SNF complex and the molecular mechanism of hSNF5 deficiency in rhabdoid tumors. | Cancer Med | 2023 | 37317642 | PubTator, text mining | PubMed |
| Group 1 and group 2 hemagglutinin stalk antibody response according to age. | Front Immunol | 2023 | 37313413 | PubTator, text mining | PubMed |
| Amplification of the poorer ear by StereoBiCROS in case of asymmetric sensorineural hearing loss: effect on tinnitus. | Front Neurosci | 2023 | 37304020 | PubTator, text mining | PubMed |
| Has_circ_0000069 expression in breast cancer and its influences on prognosis and cellular activities. | Oncol Res | 2023 | 37303741 | PubTator, text mining | PubMed |
| Hydrangea serrata Hot Water Extract and Its Major Ingredient Hydrangenol Improve Skin Moisturization and Wrinkle Conditions via AP-1 and Akt/PI3K Pathway Upregulation. | Nutrients | 2023 | 37299400 | PubTator, text mining | PubMed |
| How to Develop Drug Delivery System Based on Carbohydrate Nanoparticles Targeted to Brain Tumors. | Polymers (Basel) | 2023 | 37299315 | PubTator, text mining | PubMed |
| Exploring the Impact of Cyanidin-3-Glucoside on Inflammatory Bowel Diseases: Investigating New Mechanisms for Emerging Interventions. | Int J Mol Sci | 2023 | 37298350 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3036/papers?page=20